US3768102A - Implantable artificial urethral valve - Google Patents

Implantable artificial urethral valve Download PDF

Info

Publication number
US3768102A
US3768102A US00176759A US3768102DA US3768102A US 3768102 A US3768102 A US 3768102A US 00176759 A US00176759 A US 00176759A US 3768102D A US3768102D A US 3768102DA US 3768102 A US3768102 A US 3768102A
Authority
US
United States
Prior art keywords
valve
occluding member
bladder
tunnel
occluding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00176759A
Inventor
Gett C Kwan
S Jacobsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation UURF
University of Utah
Original Assignee
University of Utah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah filed Critical University of Utah
Application granted granted Critical
Publication of US3768102A publication Critical patent/US3768102A/en
Assigned to UNIVERSITY OF UTAH RESEARCH FONDATION, (FOUNDATION) reassignment UNIVERSITY OF UTAH RESEARCH FONDATION, (FOUNDATION) ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: UNIVERSITY OF UTAH, BY ARVO VAN ALSTYNE, VICE PRESIDENT-EXECUTIVE ASSISTANT.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0022Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed deep in the body opening
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K15/00Check valves
    • F16K15/02Check valves with guided rigid valve members
    • F16K15/025Check valves with guided rigid valve members the valve being loaded by a spring
    • F16K15/026Check valves with guided rigid valve members the valve being loaded by a spring the valve member being a movable body around which the medium flows when the valve is open
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K15/00Check valves
    • F16K15/02Check valves with guided rigid valve members
    • F16K15/04Check valves with guided rigid valve members shaped as balls
    • F16K15/044Check valves with guided rigid valve members shaped as balls spring-loaded
    • F16K15/046Check valves with guided rigid valve members shaped as balls spring-loaded by a spring other than a helicoidal spring
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K2200/00Details of valves
    • F16K2200/30Spring arrangements
    • F16K2200/305Constructional features of springs
    • F16K2200/3052Cantilever springs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/25Artificial sphincters and devices for controlling urinary incontinence
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/7722Line condition change responsive valves
    • Y10T137/7837Direct response valves [i.e., check valve type]
    • Y10T137/7904Reciprocating valves
    • Y10T137/7922Spring biased
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/7722Line condition change responsive valves
    • Y10T137/7837Direct response valves [i.e., check valve type]
    • Y10T137/7904Reciprocating valves
    • Y10T137/7922Spring biased
    • Y10T137/7925Piston-type valves
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/7722Line condition change responsive valves
    • Y10T137/7837Direct response valves [i.e., check valve type]
    • Y10T137/7904Reciprocating valves
    • Y10T137/7922Spring biased
    • Y10T137/7927Ball valves

Definitions

  • An artificial urethral valve for implantation in the bladder or urethra of an incontinent person comprising a movable valve occluding means which is retained in the closed position by means of a spring that requires a relatively high opening force and then substantially collapses to allow the passage of bladder contents through the valve.
  • the valve occluding member retaining spring requires a relatively high breakaway or opening force to open. Thereafter the normal outflow of bladder contents through the valve is sufficient to substantially keep the valve open. After the contents of the bladder have been voluntarily evacuated, the valve occluding member is automatically returned to the valve seat to again close the valve to a leakproof seal.
  • One such method of caring for involuntary bladder emissions consists of the incontinent person wearing a pad of absorbant material in close proximity to the external opening of the urethra to absorb all the fluid that escapes past the malfunctioning natural urethral valve.
  • This method is very undesirable in-that the wearer is continually confronted with the embarrassment of having to wear a bulky pad of absorbant material that-can create skin irritations and offensive odors.
  • a person thus equipped will of necessity feel-unduly restricted in his activities since he'must always be aware of the problems associated with urination, used pad removal and disposal, and pad replacement. 7
  • the appendage or plug portion of their device thatpasses out through the urethra] sphincter muscle is smaller in diameter thanthe internal diameter of the urethra but of sufficient diameter to form a fluids barrier whenthe urethral sphincter muscle is closed about it.
  • Their invention is adaptable only for those persons who are able to partially close the uethral sphincter muscle sufficiently to completely restrict the urethra when the plug is located within the confines of the muscle and thus overcome incontinence of urination.
  • cord'in their invention which extends out the urethra (see column 4, lines 3236 is such a source of irritation to the urethra since it would reside withinthe urethra while the appliance is in place as a method of overcoming incontinence.
  • the apparatus of the present invention does not require the use of any external appliances as disclosed by Snyder or the adaptationof other voluntary muscles to the task of supplying motive power to a urethral closure device located externally of the urethra as disclosed by Berry, U. S. Pat. No. 3,066,667.
  • Berry discloses an inert and rigid body that is pressed against the urethra to pinch it closed or otherwise cause the urethra to be kinked in such a manner as to prevent the passage of bladder contents through the urethra. From the foregoing, a serious question arises as to whether the pinching of the living tissue will tend to cause necrosis of that section of tissue.
  • the present invention completely replaces the natural urethral sphincter muscle as the urethra closure means and utilizes only the normal muscles used in urination to create sufficient pressure upon the bladder contents to overcome the spring tension force that holds the occluding member'to the valve seat to form the leakproof seal. Once the initial spring tension-force is overcome, the valve will remain open under the normal flow of the bladder contents with very little pressure required to be exerted upon the bladder to-keep the" valve open and the bladder contents flowing.
  • FIG. 1 is a schematic of one embodiment of the'artifi cal urethral valve with a spherical occluding',member.
  • FlG. 2 is a schematic of another embodiment of the artifical urethral valve with a conical occluding member.
  • FIG. 3 is an end view of both embodiments set forth in FIGS. 1 and 2.
  • an artificial urethral valve is shown generally at 10 and comprises a fluids occluding member 11 in the shape of a sphere which occludes the distal end of the inlet portion 12 of a tunnel through the body of the valve when held by the spring tension force of a spring 17 against a valve seat 14.
  • Valve seat 14 is formed circumferentially about the distal end of the inlet tunnel 12.
  • the diameter of occluding member 1 1 is less than the internal diameter of the cavity or tunnel within which it resides to allow the passage of bladder contents through the valve once the occluding member has been dislodged from the valve seat 14.
  • the spring tension force of spring 17 acting upon occluding member 11 is sufficient to return occluding member 11 to valve seat 14 and again form a leakproof seal.
  • the artificial urethral valve very closely approximates the functions of a normally functioning natural urethral valve.
  • Spring 17 is' in the form of a'spring that has relatively high resistance to movement up to a certain point but movement beyond that point causes the spring to substantially collapse to a condition of weaker resilience.
  • a spring is similar to the common noisemaker or cricket which has-a leaf of spring metal with a depression or dimple formed therein which creates the high resistance to movement up to a point after which the spring collapses with a loud noise to the condition of weaker resistance.
  • Spring 17 is also similar in principle to the commercially available Belleville spring wherein opposing compressive and tensive forces within the body of the spring create the condition of relatively high resistance to movement up to a certain point and any movement beyond that point causes the spring to substantially collapse to a condition of weaker resistance.
  • occluding member 11 is held against valve seat 14 until forced away by the .voluntary exertion of force sufficient to cause urination at which time spring 17 substantially collapses and allows occluding member 11 to move away from valve seat 14 to allow the bladder contents to be evacuated through the valve.
  • the flow of the bladder contents through the valve is sufficient to overcome the resilience of spring 17 in its substantially collapsed state.
  • the remaining resilience of the substantially collapsed spring 17 is sufficient to return occluding member 11 to the closed position against valve seat 14 whereupon the spring again requires a relatively high force to open the valve.
  • an artificial urethral valve as shown is designed for implantation in the bladder over the bladder outlet to the urethra in such a manner as to completely control the outflow of bladder contents into the urethra and subsequently from the body.
  • occluding member 11 is generally in the form of a right circular cone with a blunted apex and gently rounded corners.
  • the apex of the cone resides within the inlet tunnel 12 and the sloping sides of the cone contact valve seat-14 to form a leakproof seal.
  • This cone shape of the occluding member causes it to act as a lifting body under the flow of bladder contents in that the flow of fluids around the cone shape in a direction generally parallel to the axis of the cone will tend to create an area of decreased pressure behind the cone. This area of decreased pressure will in turn assist in the movement of the occluding member 1 1 further from the valveseat l4 and in overcoming the resistance of spring 17.
  • the cone shape is merely one suggested embodiment of the occluding member 11.
  • Other forms or shapes could easily be adapted for use as an occluding member for the artificial urethral valve.
  • FIG. 3 is an end view of the valves shown in FIGS. 1 and 2 and serves to illustrate how openings 15 between restraining members 16 allow the passage of bladder contents fromthe valve into the urethra. In all embodiments, restraining members 16 prevent the downstream travel of occluding member 11.
  • all materials of construction in contact with living tissue are inert and non-irritating to living tissue in addition to being inert to urine wherever the materials come into actual contact with the bladder contents.
  • the artificial urethral valve shown could be surgically implanted in the appropriate position in the lower urinary tract of the incontinent person; however, it could also be constructed of such av small external diameter that it could be inserted through the external opening of the urethra and up the urethra until in a position proximal to the natural urethral valve muscle such that the natural urethral valve muscle would retain the artificial urethral valve in place.
  • the artificial urethral valve could be bonded in place by means of tissue compatible adhesives or by means of expandable barbs that could be expanded when the valve is in place to engage the inner wall of the urethra sufficient to hold the valve in place in the uethra against the pressures of the bladder contents.
  • an artificial .urethral valve for implantation inimplanting and blocking the lower urinary tract of the incontinent person and, having a tunnel which extends therethrough for the passage of bladder contents through said valve body wherein the internal diameter of a first downstream portion of the inlet section of said tunnel is of a lesser diameter than an adjacent second downstream section of said tunnel, the downstream face of said lesser diameter portion being located in a plane generally transverse to the longitudinal axis of said tunnel and serving as a valve seat for an occluding member of said valve tunnel, which occluding member resides within the second section of the tunnel downstream of said valve seat, said occluding memberbeing held in the occluding position against said valve seat by the resilience of a spring means, said spring means having a first greater resiliency to movement to a predetermined position away from said seat and thereafter substantially collapses to a condition of lesser resiliency under a force exerted upon the bladder contents sufficient to initiate urination whereupon said occluding member
  • said occluding member is in the shape generally of an apex of a blunted cone wherein the blunted tip of said cone resides within the center of said valve seat and the sloping sides of said cone serve as a liquid proof contact between said valve seat and said occluding member said occluding member acting as a lifting body under a flow of bladder contents through said tunnel, said lifting body action serving to assist in overcoming any remaining resistive force tending to return said occluding member to said valve seat.
  • An implantable artificial urethral valve comprising valving means operable under a first, greater pressure to open said valve and retained in said open position under a second, lesser, pressure, said valving means comprising a body of a size to be implanted wholly Within the lower urinary tract, a tunnel extending through said body having a valve seat therein, an occluding member engaging said seat, and a spring engaging said occluding member to normally retain said occluding member against said valve seat in a sealing relationship until opened by said first greater pressure, said spring having a first greater resiliency to movement to a predetermined position away from said seat and a second lesser resiliency to movement beyond said predetermined position.

Abstract

An artificial urethral valve for implantation in the bladder or urethra of an incontinent person comprising a movable valve occluding means which is retained in the closed position by means of a spring that requires a relatively high opening force and then substantially collapses to allow the passage of bladder contents through the valve. The valve occluding member retaining spring requires a relatively high breakaway or opening force to open. Thereafter the normal outflow of bladder contents through the valve is sufficient to substantially keep the valve open. After the contents of the bladder have been voluntarily evacuated, the valve occluding member is automatically returned to the valve seat to again close the valve to a leakproof seal.

Description

United States Patent [191 [11 3,768,102 1 Oct. 30, 1973 Kwan-Ge tt et a1.
City, Utah; Stephen C. Jacobsen, Arlington, Mass.
[73] Assignee: University of Utah, Salt Lake City,
Utah
[22] Filed: Feb. 3, 1972 [21] Appl.No.: 176,759
Related US. Application Data '[62] Division of Ser. No. 849,720, Aug. 13, 1969,
abandoned.
[52] US. Cl. 3/1, 128/1 R, 128/349 R, 128/DIG.25,137/535,137/538, 137/539 [51] Int. Cl ..A61f1/00, A6lf l/24 [58] Field of Search 3/1; 128/1 R, 348-351,-
128/DIG. 25; 137/535, 538, 539
837,009 4/1952 Germany 128/349 R 11,158 0/1892 Great Britain 137/535 OTHER PUBLICATIONS A Mechanical Urethral Valve, by F. P. Kohler et al., The Bulletin of the Dow Corning Center for Aid to Medical Research, Vol. 2, No. 2, Apr. 1960.
Primary Examiner-Richard A. Gaudet Assistant ExaminerRonald L. Frinks Att0rrieyClarence W. Martin 57 1 ABSTRACT An artificial urethral valve for implantation in the bladder or urethra of an incontinent person comprising a movable valve occluding means which is retained in the closed position by means of a spring that requires a relatively high opening force and then substantially collapses to allow the passage of bladder contents through the valve. The valve occluding member retaining spring requires a relatively high breakaway or opening force to open. Thereafter the normal outflow of bladder contents through the valve is sufficient to substantially keep the valve open. After the contents of the bladder have been voluntarily evacuated, the valve occluding member is automatically returned to the valve seat to again close the valve to a leakproof seal.
5 Claims, 3 Drawing Figures 'PA IENTEMm somsv 3.768102 INVENTORS CLIFFORD S. K WAN-GE 77' BY STEPHEN C. JACOBSEN WWW IMPLANTABLE ARTIFICIAL URETHRAL VALVE This is a division of an application for US. Pat. Ser. No. 849,720, filed Aug. 13, 1969 and now abandoned.
Voluntary control over the discharge of bladder contents has long been a serious and -distressing problem for persons whose natural urethral valve is no longer capable of completely controlling the outflow of urine from the bladder for such reasons as advanced age, surgery, disease, or malformation of the natural urethral valve. Persons with this problem have attempted other means of control or correction which have proved to be uncomfortable, inconvenient, unsanitary, offensive, and inadequate.
One such method of caring for involuntary bladder emissions consists of the incontinent person wearing a pad of absorbant material in close proximity to the external opening of the urethra to absorb all the fluid that escapes past the malfunctioning natural urethral valve. This method is very undesirable in-that the wearer is continually confronted with the embarrassment of having to wear a bulky pad of absorbant material that-can create skin irritations and offensive odors. A person thus equipped will of necessity feel-unduly restricted in his activities since he'must always be aware of the problems associated with urination, used pad removal and disposal, and pad replacement. 7
Another method of caring for involuntary urinary emissions has been for the incontinent person to wear a receiving container-attached to the leg or suspended from the waist and connected to the external opening of the urethra in such a manner as to allow the urine to flow by the force of graivty into the receiving container. Such a device is disclosed by Snyder, U. S. Pat. No. 3,447,536. Not only is such a device cumbersome, but it can be odoriferous and has on occasion been known to spill or otherwise accidently discharge its contents.
Neither of the foregoing methods is directed towards solving the underlying problem of the incontinent person nor do they attempt to return the evacuation of bladder contents to the completelyvoluntary control of the afflicted person. i
Beliveau et al., U. S. Pat. No. 3,372,695, propose a device that is inserted up the urethra until a retainer portion resides inside the bladder and an appendage thereto or plug passes outof the bladder into the ure-,
thra such that the plug resides within the confines of the urethral sphincter muscle. The appendage or plug portion of their device thatpasses out through the urethra] sphincter muscle is smaller in diameter thanthe internal diameter of the urethra but of sufficient diameter to form a fluids barrier whenthe urethral sphincter muscle is closed about it. Their invention is adaptable only for those persons who are able to partially close the uethral sphincter muscle sufficiently to completely restrict the urethra when the plug is located within the confines of the muscle and thus overcome incontinence of urination. Their invention would not be usable in a person who was unable to exercise any form of voluntary control over the urethral sphincter muscle or in a person whose urethral sphincter muscle has been damaged by disease such that the plug portion would not complete the seal when acted upon by the muscle. Nor would it be operable in a person whose urethral sphincter muscle has been surgically removed for one reason or another. Also, it is well known in the medical field that an unrestrained foreign object in the urethra is a source of irritation to the lining of the urethra and substantially increases the dangers of infection of the urethra. The cord'in their invention, which extends out the urethra (see column 4, lines 3236 is such a source of irritation to the urethra since it would reside withinthe urethra while the appliance is in place as a method of overcoming incontinence.
The apparatus of the present invention does not require the use of any external appliances as disclosed by Snyder or the adaptationof other voluntary muscles to the task of supplying motive power to a urethral closure device located externally of the urethra as disclosed by Berry, U. S. Pat. No. 3,066,667. Berry discloses an inert and rigid body that is pressed against the urethra to pinch it closed or otherwise cause the urethra to be kinked in such a manner as to prevent the passage of bladder contents through the urethra. From the foregoing, a serious question arises as to whether the pinching of the living tissue will tend to cause necrosis of that section of tissue.
The present invention completely replaces the natural urethral sphincter muscle as the urethra closure means and utilizes only the normal muscles used in urination to create sufficient pressure upon the bladder contents to overcome the spring tension force that holds the occluding member'to the valve seat to form the leakproof seal. Once the initial spring tension-force is overcome, the valve will remain open under the normal flow of the bladder contents with very little pressure required to be exerted upon the bladder to-keep the" valve open and the bladder contents flowing.
After the bladder contents have been evacuated, there is sufficient spring tension in the resilient member to return the occluding member to the closed position to form again a leakproof seal.
It is an object of this invention to provide an artificial urethral valve suitable for implantation in the urethra or bladder of an incontinent person for the purpose of returning the evacuation of bladdercontents to the voluntary control of the user.
A further object of this invention is to provide an artificial urethral valve that requires an opening force greater than the static pressures normally exertedon the bladder and thereafter-remains open under avminimal force such as the gravitational flow of urine from the bladder. 4 v v A still further object of this invention is to provide an artificial urethral valve that automatically returns-to the closed position when the contents of thebladder have been voluntarily evacuated. v
, These and other objects and advantages of the present invention will become apparent from the following drawing and accompanying descriptionsof the draw- FIG. 1 is a schematic of one embodiment of the'artifi cal urethral valve with a spherical occluding',member. FlG. 2 is a schematic of another embodiment of the artifical urethral valve with a conical occluding member.
FIG. 3 is an end view of both embodiments set forth in FIGS. 1 and 2.
Referring to FIG. 1, an artificial urethral valve is shown generally at 10 and comprises a fluids occluding member 11 in the shape of a sphere which occludes the distal end of the inlet portion 12 of a tunnel through the body of the valve when held by the spring tension force of a spring 17 against a valve seat 14. Valve seat 14 is formed circumferentially about the distal end of the inlet tunnel 12. When dislodged from the valve seat 14 by the voluntary exertion of force upon the bladder and its contents sufficient to initiate urination, occluding member 11 is forced away from valve seat 14 whereupon the spring tension force of spring 17 tending to return occluding member 11 to valve seat 14 rapidly collapses. Once dislodged from valve seat 14, occluding member 11 is held away from the valve seat by the force of the flow of bladder contents through inlet tunnel 12 of valve 10.
The diameter of occluding member 1 1 is less than the internal diameter of the cavity or tunnel within which it resides to allow the passage of bladder contents through the valve once the occluding member has been dislodged from the valve seat 14.
After the bladder contents have been voluntarilyevacuated, the spring tension force of spring 17 acting upon occluding member 11 is sufficient to return occluding member 11 to valve seat 14 and again form a leakproof seal. In this manner, the artificial urethral valve very closely approximates the functions of a normally functioning natural urethral valve.
Spring 17 is' in the form of a'spring that has relatively high resistance to movement up to a certain point but movement beyond that point causes the spring to substantially collapse to a condition of weaker resilience. Such a spring is similar to the common noisemaker or cricket which has-a leaf of spring metal with a depression or dimple formed therein which creates the high resistance to movement up to a point after which the spring collapses with a loud noise to the condition of weaker resistance. Spring 17 is also similar in principle to the commercially available Belleville spring wherein opposing compressive and tensive forces within the body of the spring create the condition of relatively high resistance to movement up to a certain point and any movement beyond that point causes the spring to substantially collapse to a condition of weaker resistance.
Utilizing this type of spring, occluding member 11 is held against valve seat 14 until forced away by the .voluntary exertion of force sufficient to cause urination at which time spring 17 substantially collapses and allows occluding member 11 to move away from valve seat 14 to allow the bladder contents to be evacuated through the valve. The flow of the bladder contents through the valve is sufficient to overcome the resilience of spring 17 in its substantially collapsed state. After the flow has ceased, the remaining resilience of the substantially collapsed spring 17 is sufficient to return occluding member 11 to the closed position against valve seat 14 whereupon the spring again requires a relatively high force to open the valve.
It would be obvious to one skilled in the surgical arts that an artificial urethral valve as shown is designed for implantation in the bladder over the bladder outlet to the urethra in such a manner as to completely control the outflow of bladder contents into the urethra and subsequently from the body.
Referring to FIG. 2, occluding member 11 is generally in the form of a right circular cone with a blunted apex and gently rounded corners. The apex of the cone resides within the inlet tunnel 12 and the sloping sides of the cone contact valve seat-14 to form a leakproof seal. This cone shape of the occluding member causes it to act as a lifting body under the flow of bladder contents in that the flow of fluids around the cone shape in a direction generally parallel to the axis of the cone will tend to create an area of decreased pressure behind the cone. This area of decreased pressure will in turn assist in the movement of the occluding member 1 1 further from the valveseat l4 and in overcoming the resistance of spring 17.
The cone shape is merely one suggested embodiment of the occluding member 11. Other forms or shapes could easily be adapted for use as an occluding member for the artificial urethral valve.
FIG. 3 is an end view of the valves shown in FIGS. 1 and 2 and serves to illustrate how openings 15 between restraining members 16 allow the passage of bladder contents fromthe valve into the urethra. In all embodiments, restraining members 16 prevent the downstream travel of occluding member 11.
In all embodiments of theartificial urethral valve all materials of construction in contact with living tissue are inert and non-irritating to living tissue in addition to being inert to urine wherever the materials come into actual contact with the bladder contents.
The artificial urethral valve shown could be surgically implanted in the appropriate position in the lower urinary tract of the incontinent person; however, it could also be constructed of such av small external diameter that it could be inserted through the external opening of the urethra and up the urethra until in a position proximal to the natural urethral valve muscle such that the natural urethral valve muscle would retain the artificial urethral valve in place. As an alternative, the artificial urethral valve could be bonded in place by means of tissue compatible adhesives or by means of expandable barbs that could be expanded when the valve is in place to engage the inner wall of the urethra sufficient to hold the valve in place in the uethra against the pressures of the bladder contents.
We claim:
1. In an artificial .urethral valve for implantation inimplanting and blocking the lower urinary tract of the incontinent person and, having a tunnel which extends therethrough for the passage of bladder contents through said valve body wherein the internal diameter of a first downstream portion of the inlet section of said tunnel is of a lesser diameter than an adjacent second downstream section of said tunnel, the downstream face of said lesser diameter portion being located in a plane generally transverse to the longitudinal axis of said tunnel and serving as a valve seat for an occluding member of said valve tunnel, which occluding member resides within the second section of the tunnel downstream of said valve seat, said occluding memberbeing held in the occluding position against said valve seat by the resilience of a spring means, said spring means having a first greater resiliency to movement to a predetermined position away from said seat and thereafter substantially collapses to a condition of lesser resiliency under a force exerted upon the bladder contents sufficient to initiate urination whereupon said occluding member is held away from said occluding position by i the force of the outflow of bladder contents from the bladder through said valve body until said outflow of said bladder contents has substantially ceased whereupon the residual resilience of said spring is sufficient to return said occluding member to said occluding position.
2. in an artificial urethral valve as defined in claim 1 wherein said occluding member is in the shape generally of an apex of a blunted cone wherein the blunted tip of said cone resides within the center of said valve seat and the sloping sides of said cone serve as a liquid proof contact between said valve seat and said occluding member said occluding member acting as a lifting body under a flow of bladder contents through said tunnel, said lifting body action serving to assist in overcoming any remaining resistive force tending to return said occluding member to said valve seat.
3. An artificial urethral valve as defined in claim 1 wherein all materials of construction exposed to living tissue are inert to and compatible with living tissue.
4. An artificial urethral valve as defined in claim 1 wherein all materials of construction exposed to bladder contents are inert to said bladder contents.
5. An implantable artificial urethral valve comprising valving means operable under a first, greater pressure to open said valve and retained in said open position under a second, lesser, pressure, said valving means comprising a body of a size to be implanted wholly Within the lower urinary tract, a tunnel extending through said body having a valve seat therein, an occluding member engaging said seat, and a spring engaging said occluding member to normally retain said occluding member against said valve seat in a sealing relationship until opened by said first greater pressure, said spring having a first greater resiliency to movement to a predetermined position away from said seat and a second lesser resiliency to movement beyond said predetermined position.

Claims (5)

1. In an artificial urethral valve for implantation in the lower urinary tract of an incontinent person for the purpose of allowing the incontinent person to regain voluntary control over the evacuation of bladder contents, said valve comprising a body of a size for wholly implanting and blocking the lower urinary tract of the incontinent person and having a tunnel which extends therethrough for the passage of bladder contents through said valve body wherein the internal diameter of a first downstream portion of the inlet section of said tunnel is of a lesser diameter than an adjacent second downstream section of said tunnel, the downstream face of said lesser diameter portion being located in a plane generally transverse to the longitudinal axis of said tunnel and serving as a valve seat for an occluding member of said valve tunnel, which occluding member resides within the second section of the tunnel downstream of said valve seat, said occluding member being held in the occluding position against said valve seat by the resilience of a spring means, said spring means having a first greater resiliency to movement to a predetermined position away from said seat and thereafter substantially collapses to a condition of lesser resiliency under a force exerted upon the bladder contents sufficient to initiate urination whereupon said occluding member is held away from said occluding position by the force of the outflow of bladder contents from the bladder through said valve body until said outflow of said bladder contents has substantially ceased whereupon the residual resilience of said spring is sufficient to return said occluding member to said occluding position.
2. In an artificial urethral valve as defined in claim 1 wherein said occluding member is in the shape generally of an apex of a blunted cone wherein the blunted tip of said cone resides within the center of said valve seat and the sloping sides of said cone serve as a liquid proof contact between said valve seat and said occluding member said occluding member acting as a lifting body under a flow of bladdEr contents through said tunnel, said lifting body action serving to assist in overcoming any remaining resistive force tending to return said occluding member to said valve seat.
3. An artificial urethral valve as defined in claim 1 wherein all materials of construction exposed to living tissue are inert to and compatible with living tissue.
4. An artificial urethral valve as defined in claim 1 wherein all materials of construction exposed to bladder contents are inert to said bladder contents.
5. An implantable artificial urethral valve comprising valving means operable under a first, greater pressure to open said valve and retained in said open position under a second, lesser, pressure, said valving means comprising a body of a size to be implanted wholly within the lower urinary tract, a tunnel extending through said body having a valve seat therein, an occluding member engaging said seat, and a spring engaging said occluding member to normally retain said occluding member against said valve seat in a sealing relationship until opened by said first greater pressure, said spring having a first greater resiliency to movement to a predetermined position away from said seat and a second lesser resiliency to movement beyond said predetermined position.
US00176759A 1972-02-03 1972-02-03 Implantable artificial urethral valve Expired - Lifetime US3768102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17675972A 1972-02-03 1972-02-03

Publications (1)

Publication Number Publication Date
US3768102A true US3768102A (en) 1973-10-30

Family

ID=22645707

Family Applications (1)

Application Number Title Priority Date Filing Date
US00176759A Expired - Lifetime US3768102A (en) 1972-02-03 1972-02-03 Implantable artificial urethral valve

Country Status (1)

Country Link
US (1) US3768102A (en)

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3858571A (en) * 1973-07-02 1975-01-07 Arthur I Rudolph Cornual plug
US3942687A (en) * 1974-10-02 1976-03-09 Possis Corporation Applicator for molten thermoplastic adhesives
FR2297031A1 (en) * 1975-01-07 1976-08-06 Rhone Poulenc Ind Closure device for implantable tubes - having soft, flexible cylindrical hollow body,and openable flexible closure within body
FR2388544A1 (en) * 1977-04-25 1978-11-24 Astra Sjuco Ab DEVICE FOR BLADDER REHABILITATION
US4168708A (en) * 1977-04-20 1979-09-25 Medical Engineering Corp. Blood vessel occlusion means suitable for use in anastomosis
US4193576A (en) * 1977-12-30 1980-03-18 J & D Enterprises Self-flushing ball seal disconnect
US4209010A (en) * 1978-07-26 1980-06-24 The Kendall Company Artificial sphincter
US4210132A (en) * 1978-07-26 1980-07-01 The Kendall Company Artificial sphincter
US4210131A (en) * 1978-07-26 1980-07-01 The Kendall Company Artificial sphincter with collection bag
US4233982A (en) * 1977-11-24 1980-11-18 Richard Wolf Gmbh Trocar sleeves having a ball valve
US4281658A (en) * 1979-07-09 1981-08-04 Child Laboratories, Inc. Dilator
US4379458A (en) * 1977-11-24 1983-04-12 Richard Wolf Gmbh Trocar sleeves having a ball valve
US4421510A (en) * 1979-01-18 1983-12-20 Ahlbeck Stig Goran Urine drainage device permitting training of the bladder
US4457299A (en) * 1981-02-06 1984-07-03 Cornwell George H I Incontinence control devices
EP0193406A2 (en) * 1985-02-28 1986-09-03 Medtronic, Inc. Device for controlling incontinence
DE3522277A1 (en) * 1984-04-17 1987-01-02 Richards Medical Co PROSTHETIC DEVICE AND PARACENTES TUBE
US4679546A (en) * 1984-10-17 1987-07-14 Applied Medical Technics B.V. Implantable shut-off device
US4850393A (en) * 1988-08-01 1989-07-25 Rockland Form-A-Plastic, Inc. All-plastic check valve
US4863477A (en) * 1987-05-12 1989-09-05 Monson Gary L Synthetic intervertebral disc prosthesis
US4909785A (en) * 1986-03-25 1990-03-20 American Medical Systems, Inc. Method for valving body fluids
US4946449A (en) * 1986-12-18 1990-08-07 Davis Jr Richard C Indwelling urethral catheter system and method
US4968294A (en) * 1989-02-09 1990-11-06 Salama Fouad A Urinary control valve and method of using same
US5131906A (en) * 1988-10-20 1992-07-21 Chen Fusen H Incontinence device
US5306226A (en) * 1989-02-09 1994-04-26 Salama Fouad A Urinary control with inflatable seal and method of using same
US5360407A (en) * 1991-08-29 1994-11-01 C. R. Bard, Inc. Implantable dual access port with tactile ridge for position sensing
US5386836A (en) * 1986-10-14 1995-02-07 Zedlani Pty Limited Urinary incontinence device
US5399168A (en) * 1991-08-29 1995-03-21 C. R. Bard, Inc. Implantable plural fluid cavity port
US5624395A (en) * 1995-02-23 1997-04-29 Cv Dynamics, Inc. Urinary catheter having palpitatable valve and balloon and method for making same
US5906575A (en) * 1996-04-25 1999-05-25 Rochester Medical Corporation Urethral urine retention device
EP0918495A1 (en) * 1996-08-13 1999-06-02 Galt Laboratories, Inc. Device for maintaining urinary continence
US5935137A (en) * 1997-07-18 1999-08-10 Gynecare, Inc. Tubular fallopian sterilization device
US5964732A (en) * 1997-02-07 1999-10-12 Abbeymoor Medical, Inc. Urethral apparatus with position indicator and methods of use thereof
US5971967A (en) * 1997-08-19 1999-10-26 Abbeymoor Medical, Inc. Urethral device with anchoring system
US6254638B1 (en) * 1996-09-16 2001-07-03 Paul Ferdinand Schouwenburg Voice prosthesis with biomedical sealing on the circumference
US6464999B1 (en) 1998-06-17 2002-10-15 Galt Incorporated Bioadhesive medical devices
US20020173698A1 (en) * 2001-05-15 2002-11-21 Morningstar Randy L. Implantable medical balloon and method of making
US20030047216A1 (en) * 2001-09-07 2003-03-13 Kelly Paul A. Pop-type pressure relief valve
US6616624B1 (en) 2000-10-30 2003-09-09 Cvrx, Inc. Systems and method for controlling renovascular perfusion
US6679266B2 (en) 1995-06-07 2004-01-20 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6684884B2 (en) 1995-06-07 2004-02-03 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US20050005973A1 (en) * 2002-06-04 2005-01-13 Werner Haarer Pressure regulator for a fuel supply system of an internal combustion engine
US20060004246A1 (en) * 2004-06-21 2006-01-05 Selikowitz Stuart M Surgically implantable perineal urinary incontinence device
US20060196554A1 (en) * 2003-03-03 2006-09-07 Werner Haarer Pressure regulator
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
US9763762B2 (en) 2013-09-25 2017-09-19 Medtronic, Inc. Implantable urinary tract valve
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
US10327880B2 (en) 2000-04-14 2019-06-25 Attenuex Technologies, Inc. Attenuation device for use in an anatomical structure
US10383510B2 (en) 2000-04-14 2019-08-20 Solace Therapeutics, Inc. Implant with high vapor pressure medium
US10531894B2 (en) 2012-08-10 2020-01-14 Solace Therapeutics, Inc. Methods and systems for performing a medical procedure
US10857324B2 (en) 2014-08-26 2020-12-08 C. R. Bard, Inc. Urinary catheter
US11197981B2 (en) 2019-02-07 2021-12-14 Solace Therapeutics, Inc. Pressure attenuation device
US11547599B2 (en) 2017-09-19 2023-01-10 C. R. Bard, Inc. Urinary catheter bridging device, systems and methods thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE837009C (en) * 1950-09-22 1952-04-17 Dr Med Erich Kratschmer Closure for prostate hypertrophy permanent catheter
US3503400A (en) * 1967-07-12 1970-03-31 Sven M Osthagen Urethral valve

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE837009C (en) * 1950-09-22 1952-04-17 Dr Med Erich Kratschmer Closure for prostate hypertrophy permanent catheter
US3503400A (en) * 1967-07-12 1970-03-31 Sven M Osthagen Urethral valve

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A Mechanical Urethral Valve , by F. P. Kohler et al., The Bulletin of the Dow Corning Center for Aid to Medical Research, Vol. 2, No. 2, Apr. 1960. *

Cited By (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3858571A (en) * 1973-07-02 1975-01-07 Arthur I Rudolph Cornual plug
US3942687A (en) * 1974-10-02 1976-03-09 Possis Corporation Applicator for molten thermoplastic adhesives
FR2297031A1 (en) * 1975-01-07 1976-08-06 Rhone Poulenc Ind Closure device for implantable tubes - having soft, flexible cylindrical hollow body,and openable flexible closure within body
US4168708A (en) * 1977-04-20 1979-09-25 Medical Engineering Corp. Blood vessel occlusion means suitable for use in anastomosis
FR2388544A1 (en) * 1977-04-25 1978-11-24 Astra Sjuco Ab DEVICE FOR BLADDER REHABILITATION
US4233982A (en) * 1977-11-24 1980-11-18 Richard Wolf Gmbh Trocar sleeves having a ball valve
US4379458A (en) * 1977-11-24 1983-04-12 Richard Wolf Gmbh Trocar sleeves having a ball valve
US4193576A (en) * 1977-12-30 1980-03-18 J & D Enterprises Self-flushing ball seal disconnect
US4210131A (en) * 1978-07-26 1980-07-01 The Kendall Company Artificial sphincter with collection bag
US4210132A (en) * 1978-07-26 1980-07-01 The Kendall Company Artificial sphincter
US4209010A (en) * 1978-07-26 1980-06-24 The Kendall Company Artificial sphincter
US4421510A (en) * 1979-01-18 1983-12-20 Ahlbeck Stig Goran Urine drainage device permitting training of the bladder
US4281658A (en) * 1979-07-09 1981-08-04 Child Laboratories, Inc. Dilator
US4457299A (en) * 1981-02-06 1984-07-03 Cornwell George H I Incontinence control devices
DE3522277A1 (en) * 1984-04-17 1987-01-02 Richards Medical Co PROSTHETIC DEVICE AND PARACENTES TUBE
US4679546A (en) * 1984-10-17 1987-07-14 Applied Medical Technics B.V. Implantable shut-off device
EP0193406A2 (en) * 1985-02-28 1986-09-03 Medtronic, Inc. Device for controlling incontinence
EP0193406A3 (en) * 1985-02-28 1987-07-29 Medtronic, Inc. Methods for controlling incontinence
US4909785A (en) * 1986-03-25 1990-03-20 American Medical Systems, Inc. Method for valving body fluids
US5386836A (en) * 1986-10-14 1995-02-07 Zedlani Pty Limited Urinary incontinence device
US4946449A (en) * 1986-12-18 1990-08-07 Davis Jr Richard C Indwelling urethral catheter system and method
US4863477A (en) * 1987-05-12 1989-09-05 Monson Gary L Synthetic intervertebral disc prosthesis
US4850393A (en) * 1988-08-01 1989-07-25 Rockland Form-A-Plastic, Inc. All-plastic check valve
US5131906A (en) * 1988-10-20 1992-07-21 Chen Fusen H Incontinence device
US4968294A (en) * 1989-02-09 1990-11-06 Salama Fouad A Urinary control valve and method of using same
US5306226A (en) * 1989-02-09 1994-04-26 Salama Fouad A Urinary control with inflatable seal and method of using same
US5360407A (en) * 1991-08-29 1994-11-01 C. R. Bard, Inc. Implantable dual access port with tactile ridge for position sensing
US5399168A (en) * 1991-08-29 1995-03-21 C. R. Bard, Inc. Implantable plural fluid cavity port
US5624395A (en) * 1995-02-23 1997-04-29 Cv Dynamics, Inc. Urinary catheter having palpitatable valve and balloon and method for making same
US5707357A (en) * 1995-02-23 1998-01-13 C V Dynamics, Inc. Balloon catheter having palpitatable discharge valve and retention collar
US7686020B2 (en) 1995-06-07 2010-03-30 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US7428904B2 (en) 1995-06-07 2008-09-30 Alien Technology Corporation Contraceptive transcervical fallopian tube occlusion devices and their delivery
US7921848B2 (en) 1995-06-07 2011-04-12 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US8066007B2 (en) 1995-06-07 2011-11-29 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US8171936B2 (en) 1995-06-07 2012-05-08 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US8327852B2 (en) 1995-06-07 2012-12-11 Conceptus, Inc. Occlusion devices and methods
US8356599B2 (en) 1995-06-07 2013-01-22 Conceptus, Inc. Occlusion devices and methods
US6684884B2 (en) 1995-06-07 2004-02-03 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6679266B2 (en) 1995-06-07 2004-01-20 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US8733361B2 (en) 1995-06-07 2014-05-27 Bayer Essure Inc. Occlusion devices and methods
US6479000B2 (en) 1996-04-25 2002-11-12 Rochester Medical Corporation Urethral urine retention device
US6315711B1 (en) 1996-04-25 2001-11-13 Rochester Medical Corporation Urethral urine retention device
US5906575A (en) * 1996-04-25 1999-05-25 Rochester Medical Corporation Urethral urine retention device
EP0918495A1 (en) * 1996-08-13 1999-06-02 Galt Laboratories, Inc. Device for maintaining urinary continence
EP0918495A4 (en) * 1996-08-13 2002-03-06 Galt Lab Inc Device for maintaining urinary continence
US6254638B1 (en) * 1996-09-16 2001-07-03 Paul Ferdinand Schouwenburg Voice prosthesis with biomedical sealing on the circumference
US6258060B1 (en) 1997-02-07 2001-07-10 Abbeymoon Medical, Inc. Urethral apparatus with position indicator and methods of use thereof
US5964732A (en) * 1997-02-07 1999-10-12 Abbeymoor Medical, Inc. Urethral apparatus with position indicator and methods of use thereof
US5935137A (en) * 1997-07-18 1999-08-10 Gynecare, Inc. Tubular fallopian sterilization device
US6221060B1 (en) 1997-08-19 2001-04-24 Abbeymoor Medical, Inc. Urethral device with anchoring system
US5971967A (en) * 1997-08-19 1999-10-26 Abbeymoor Medical, Inc. Urethral device with anchoring system
US8613282B2 (en) 1997-09-24 2013-12-24 Conceptus, Inc. Occlusion devices and methods
US8733360B2 (en) 1997-09-24 2014-05-27 Bayer Essure Inc. Occlusion devices and methods
US6464999B1 (en) 1998-06-17 2002-10-15 Galt Incorporated Bioadhesive medical devices
US10327880B2 (en) 2000-04-14 2019-06-25 Attenuex Technologies, Inc. Attenuation device for use in an anatomical structure
US10383510B2 (en) 2000-04-14 2019-08-20 Solace Therapeutics, Inc. Implant with high vapor pressure medium
US7485104B2 (en) 2000-10-30 2009-02-03 Cvrx, Inc. Systems and methods for controlling renovascular perfusion
US6616624B1 (en) 2000-10-30 2003-09-09 Cvrx, Inc. Systems and method for controlling renovascular perfusion
US20030199806A1 (en) * 2000-10-30 2003-10-23 Cvrx, Inc. Systems and methods for controlling renovascular perfusion
US20020173698A1 (en) * 2001-05-15 2002-11-21 Morningstar Randy L. Implantable medical balloon and method of making
US7160325B2 (en) * 2001-05-15 2007-01-09 Ams Research Corporation Implantable medical balloon and valve
US20030047216A1 (en) * 2001-09-07 2003-03-13 Kelly Paul A. Pop-type pressure relief valve
US7258135B2 (en) * 2002-06-04 2007-08-21 Robert Bosch Gmbh Pressure regulator for a fuel supply system of an internal combustion engine
US20050005973A1 (en) * 2002-06-04 2005-01-13 Werner Haarer Pressure regulator for a fuel supply system of an internal combustion engine
US20060196554A1 (en) * 2003-03-03 2006-09-07 Werner Haarer Pressure regulator
US7258136B2 (en) * 2003-03-03 2007-08-21 Robert Bosch Gmbh Pressure regulator
US11779372B2 (en) 2004-02-25 2023-10-10 Femasys Inc. Methods and devices for conduit occlusion
US9839444B2 (en) 2004-02-25 2017-12-12 Femasys Inc. Methods and devices for conduit occlusion
US8336552B2 (en) 2004-02-25 2012-12-25 Femasys Inc. Methods and devices for conduit occlusion
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8316853B2 (en) 2004-02-25 2012-11-27 Femasys Inc. Method and devices for conduit occlusion
US8695606B2 (en) 2004-02-25 2014-04-15 Femasys Inc. Methods and devices for conduit occlusion
US8726906B2 (en) 2004-02-25 2014-05-20 Femasys Inc. Methods and devices for conduit occlusion
US8316854B2 (en) 2004-02-25 2012-11-27 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US10292732B2 (en) 2004-02-25 2019-05-21 Femasys, Inc. Methods and devices for conduit occlusion
US9034053B2 (en) 2004-02-25 2015-05-19 Femasys Inc. Methods and devices for conduit occlusion
US9220880B2 (en) 2004-02-25 2015-12-29 Femasys Inc. Methods and devices for delivery of compositions to conduits
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US10111687B2 (en) 2004-02-25 2018-10-30 Femasys, Inc. Methods and devices for conduit occlusion
US9308023B2 (en) 2004-02-25 2016-04-12 Femasys Inc. Methods and devices for conduit occlusion
US9402762B2 (en) 2004-02-25 2016-08-02 Femasys Inc. Methods and devices for conduit occlusion
US8324193B2 (en) 2004-02-25 2012-12-04 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US7727140B2 (en) 2004-06-21 2010-06-01 Department Of Veterans Affairs Surgically implantable perineal urinary incontinence device
US20060004246A1 (en) * 2004-06-21 2006-01-05 Selikowitz Stuart M Surgically implantable perineal urinary incontinence device
US9248058B2 (en) 2005-04-12 2016-02-02 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Male external catheter with absorbent and adhesive
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US11648033B2 (en) 2008-10-03 2023-05-16 Femasys Inc. Methods and devices for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US11154326B2 (en) 2008-10-03 2021-10-26 Femasys Inc. Methods and devices for sonographic imaging
US10172643B2 (en) 2008-10-03 2019-01-08 Femasys, Inc. Contrast agent generation and injection system for sonographic imaging
US10258375B2 (en) 2008-10-03 2019-04-16 Femasys, Inc. Methods and devices for sonographic imaging
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
US10569051B2 (en) 2011-03-14 2020-02-25 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
US11607524B2 (en) 2011-03-14 2023-03-21 Rochester Medical Corporation Catheter grip and method
US10799268B2 (en) 2012-08-10 2020-10-13 Solace Therapeutics, Inc. Methods and systems for performing a medical procedure
US10543071B2 (en) 2012-08-10 2020-01-28 Solace Therapeutics, Inc. Methods and systems for performing a medical procedure
US10531894B2 (en) 2012-08-10 2020-01-14 Solace Therapeutics, Inc. Methods and systems for performing a medical procedure
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
US10780244B2 (en) 2012-11-20 2020-09-22 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter in a bag without additional packaging
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
US11730919B2 (en) 2012-11-20 2023-08-22 Rochester Medical Corporation Catheter in bag without additional packaging
US10575935B2 (en) 2013-09-25 2020-03-03 Medtronic, Inc. Implantable urinary tract valve
US9763762B2 (en) 2013-09-25 2017-09-19 Medtronic, Inc. Implantable urinary tract valve
US10857324B2 (en) 2014-08-26 2020-12-08 C. R. Bard, Inc. Urinary catheter
US10874825B2 (en) 2014-08-26 2020-12-29 C. R. Bard, Inc. Urinary catheter
US11850370B2 (en) 2014-08-26 2023-12-26 C. R. Bard, Inc. Urinary catheter
US11547599B2 (en) 2017-09-19 2023-01-10 C. R. Bard, Inc. Urinary catheter bridging device, systems and methods thereof
US11197981B2 (en) 2019-02-07 2021-12-14 Solace Therapeutics, Inc. Pressure attenuation device

Similar Documents

Publication Publication Date Title
US3768102A (en) Implantable artificial urethral valve
US5887593A (en) Urinary incontinence device
US5752525A (en) Urethral plug assembly having adhesive for enhanced sealing capabilities and method of using said plug assembly
US6527702B2 (en) Urinary flow control device and method
US5513660A (en) Expandable urethral plug
US5112306A (en) Method and apparatus for valving body fluids
US4909785A (en) Method for valving body fluids
US3903894A (en) Implantable clamp
US6623421B1 (en) External magnetic actuation valve for intraurethral artificial urinary sphincter
US5483976A (en) Mechanically actuated urethral plug assembly and method for controlling urinary incontinence
US5090424A (en) Conformable urethral plug
JP3419791B2 (en) Incontinence control device for women
WO1990004431A1 (en) Incontinence device
US20190374329A1 (en) Urethral stent and bladder control assembly comprising such a urethral stent
US5769091A (en) Urethral plug having adhesive for enhanced sealing capabilities and method of using said plug
EP0265207A1 (en) Trans-urethral incontinence device
JP7216712B2 (en) Urethral plugs and systems for treating urinary incontinence
US6171230B1 (en) Female incontinence catheter
Hajivassiliou The development and evolution of artificial urethral sphincters
KR20220113927A (en) urinary catheter with controlled drainage
ES2593973T3 (en) Synthetic urethra with closure device
US20050107771A1 (en) Device for draining urine from the human bladder
WO1997017909A1 (en) Method and device for controlling urinary incontinence
EP0769931A1 (en) An assembly and method for prevention of urinary incontinence in humans
CN117651538A (en) Improved reflective artificial sphincter

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED FILE - (OLD CASE ADDED FOR FILE TRACKING PURPOSES)